Yu-Hsuan Tuan

1PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Dec 09, 2025
Time to progression is a simple and robust prognostic factor for survival in relapsed or refractory diffuse large B-cell lymphoma.

Chieh-Lung Cheng, Tai-Chung Huang, Yu-Hsuan Tuan

Pageof 1

Frequent Collaborators

1 joint publications

Chieh-Lung Cheng

1 joint publications

Tai-Chung Huang

1 joint publications

Yun-Chun Wu